These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Review of oral cephalosporins. Basis for a rational choice]. Forti IN Medicina (B Aires); 1994; 54(5 Pt 1):439-58. PubMed ID: 7658980 [TBL] [Abstract][Full Text] [Related]
3. [Current antimicrobial drugs]. van Kasteren ME; Natsch S; van der Meer JW Ned Tijdschr Geneeskd; 1997 Dec; 141(49):2392-6. PubMed ID: 9554159 [TBL] [Abstract][Full Text] [Related]
4. Macrolides are ideal for empiric therapy of community-acquired pneumonia in the immunocompetent host. Vergis EN; Yu VL Semin Respir Infect; 1997 Dec; 12(4):322-8. PubMed ID: 9436959 [TBL] [Abstract][Full Text] [Related]
5. Antibiotics in older adults. Rodríguez-Julbe MC; Ramírez-Ronda CH; Arroyo E; Maldonado G; Saavedra S; Meléndez B; González G; Figueroa J P R Health Sci J; 2004 Mar; 23(1):25-33. PubMed ID: 15125216 [TBL] [Abstract][Full Text] [Related]
6. Diagnosis and treatment of community-acquired and hospital-acquired pneumonia. Foster MT Pharmacotherapy; 1993; 13(2 Pt 2):45S-50S. PubMed ID: 8474938 [TBL] [Abstract][Full Text] [Related]
7. The newer macrolides. Azithromycin and clarithromycin. Zuckerman JM; Kaye KM Infect Dis Clin North Am; 1995 Sep; 9(3):731-45. PubMed ID: 7490441 [TBL] [Abstract][Full Text] [Related]
8. What new antibiotics to offer in the outpatient setting. Fraser KL; Grossman RF Semin Respir Infect; 1998 Mar; 13(1):24-35. PubMed ID: 9543473 [TBL] [Abstract][Full Text] [Related]
9. The role of newer antibiotics in gastroenterology. Li E; Stanley SL Gastroenterol Clin North Am; 1992 Sep; 21(3):613-29. PubMed ID: 1516960 [TBL] [Abstract][Full Text] [Related]
10. [Role of oral fluoroquinolones in patients with respiratory diseases]. Ishida T Kekkaku; 2003 Oct; 78(10):653-9. PubMed ID: 14621574 [TBL] [Abstract][Full Text] [Related]
11. [beta-lactam-antibiotics in the treatment of community-acquired respiratory tract infections with penicillin-resistant pneumococci]. Brauers J; Ewig S; Kresken M Pneumologie; 2002 Oct; 56(10):605-9. PubMed ID: 12375222 [TBL] [Abstract][Full Text] [Related]
13. In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program. Jones RN; Pfaller MA Clin Infect Dis; 2000 Aug; 31 Suppl 2():S16-23. PubMed ID: 10984323 [TBL] [Abstract][Full Text] [Related]
14. A guide to the treatment of lower respiratory tract infections. Vogel F Drugs; 1995 Jul; 50(1):62-72. PubMed ID: 7588090 [TBL] [Abstract][Full Text] [Related]
16. The management of skin and skin structure infections in children, adolescents and adults: a review of empiric antimicrobial therapy. Wilson SE Int J Clin Pract; 1998 Sep; 52(6):414-7. PubMed ID: 9894379 [TBL] [Abstract][Full Text] [Related]
18. The role of newer oral cephalosporins, fluoroquinolones, and macrolides in the treatment of pediatric infections. Rodriguez WJ; Wiedermann BL Adv Pediatr Infect Dis; 1994; 9():125-59. PubMed ID: 8123221 [No Abstract] [Full Text] [Related]
19. Fluoroquinolones: how to use (but not overuse) these antibiotics. Sable CA; Scheld WM Geriatrics; 1993 Jun; 48(6):41-4, 49-51. PubMed ID: 8500773 [TBL] [Abstract][Full Text] [Related]
20. Acute bacterial skin infections in pediatric medicine: current issues in presentation and treatment. Hedrick J Paediatr Drugs; 2003; 5 Suppl 1():35-46. PubMed ID: 14632104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]